Excelsior Medical Co., Ltd. (TPE:4104)
78.00
-0.70 (-0.89%)
Feb 2, 2026, 1:35 PM CST
Excelsior Medical Market Cap
Excelsior Medical has a market cap or net worth of 13.5 billion as of January 30, 2026. Its market cap has decreased by -3.35% in one year.
Market Cap
13.50B
Enterprise Value
14.86B
Revenue
8.79B
Ranking
n/a
PE Ratio
16.83
Stock Price
78.00
Market Cap Chart
Since July 3, 2003, Excelsior Medical's market cap has increased from 2.50B to 13.50B, an increase of 440.33%. That is a compound annual growth rate of 7.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 13.50B | -3.55% |
| Dec 31, 2025 | 14.00B | -0.37% |
| Dec 31, 2024 | 14.05B | 2.15% |
| Dec 29, 2023 | 13.76B | 37.31% |
| Dec 30, 2022 | 10.02B | 23.23% |
| Dec 30, 2021 | 8.13B | 2.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 270.36B |
| Caliway Biopharmaceuticals | 254.97B |
| Lotus Pharmaceutical | 93.62B |
| Bora Pharmaceuticals Co., LTD. | 76.89B |
| Tanvex BioPharma | 14.78B |
| Ever Supreme Bio Technology | 13.71B |
| Handa Pharmaceuticals | 13.22B |
| Foresee Pharmaceuticals | 13.04B |